Multiple Sclerosis

Latest News

Sanofi Ends Trial of Oditrasertib
Sanofi Ends Trial of Oditrasertib

November 4th 2024

Drugmakers had hoped that inhibiting receptor-interacting protein kinase would decrease inflammation and reduce neuronal degeneration in patients with multiple sclerosis and other neurodegenerative conditions

It's Been a Bumpy Ride for the BTK Inhibitors for MS
It's Been a Bumpy Ride for the BTK Inhibitors for MS

October 14th 2024

National Multiple Sclerosis Society Grants $4.6 Million for Research in Myelin Repair
National Multiple Sclerosis Society Grants $4.6 Million for Research in Myelin Repair

October 10th 2024

collage of research | Image credit: ©Armmy Picca stock.adobe.com
Progesterone Derivative to Be Evaluated as Potential Myelin Regenerator in Research Collaboration

September 16th 2024

paper airplanes in a race | Image credit: ©Worawut stock.adobe.com
Fenebrutinib Suppresses and Disability Progression in Majority of MS Patients in Extension Study

September 11th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.